(Q48786821)

English

Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.

scientific article published in September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

1 reference

Europe PubMed Central

Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications. (English)

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

generalized anxiety disorder

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

N Casacalenda

1

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

J P Boulenger

2

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

Canadian Journal of Psychiatry

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

43

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

722-730

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

7

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

The Nottingham study of neurotic disorder: comparison of drug and psychological treatments.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

The Nottingham study of neurotic disorder. Effect of personality status on response to drug treatment, cognitive therapy and self-help over two years.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

The genetics of six neurotic disorders: a twin study

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Negative affectivity: the disposition to experience aversive emotional states

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Genetic covariation between neuroticism and the symptoms of anxiety and depression.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Symptoms of anxiety and symptoms of depression. Same genes, different environments?

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Neuroticism, extraversion, and related traits in adult twins reared apart and reared together.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Personality similarity in twins reared apart and together

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Temperament, personality, and the mood and anxiety disorders.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

A longitudinal twin study of personality and major depression in women

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Benzodiazepines in Depressive Disorders

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Benzodiazepines as antidepressants: does GABA play a role in depression?

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Alprazolam versus imipramine in depressed out-patients with neurovegetative signs

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Alprazolam vs amitriptyline in depressions with reduced REM latencies.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Exactly what does the Hamilton Depression Rating Scale measure?

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

[Dimensions of the Hamilton Depression Scale. Factor analysis studies].

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Clinical Effects of the 5-HT1A Partial Agonists in Depression

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Long-term Diazepam Therapy and Clinical Outcome

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Use of benzodiazepines in anxiety disorders

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Paroxetine efficacy in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

The occurrence of a prodrome of generalized anxiety in panic disorder.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Delimitation of generalized anxiety disorder: clinical comparisons with panic and major depressive disorders.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

The empirical basis of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Family psychiatric histories in male patients with generalized anxiety disorder and major depressive disorder.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Blunted growth hormone response to clonidine in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Comparative efficacy of antidepressants

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300707

21 January 2018

Identifiers

10.1177/070674379804300707

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9773222

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48786821&oldid=1510024257"